Evidence map›Paper›PMID 37041318›Full record

ArticlePhysical and engineering sciences in medicine2023

A deep learning nomogram of continuous glucose monitoring data for the risk prediction of diabetic retinopathy in type 2 diabetes.

Rui Tao, Xia Yu, Jingyi Lu, Yaxin Wang, Wei Lu, Zhanhu Zhang, Hongru Li, Jian Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rui TaoCollege of Information Science and Engineering, Northeastern University, Shenyang, Liaoning, China.
Xia YuCollege of Information Science and Engineering, Northeastern University, Shenyang, Liaoning, China.
Jingyi LuDepartment of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, 600 Yishan Road, Shanghai, 200233, China.
Yaxin WangDepartment of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, 600 Yishan Road, Shanghai, 200233, China.
Wei LuDepartment of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, 600 Yishan Road, Shanghai, 200233, China.
Zhanhu ZhangCollege of Information Science and Engineering, Northeastern University, Shenyang, Liaoning, China.
Hongru LiCollege of Information Science and Engineering, Northeastern University, Shenyang, Liaoning, China.
Jian ZhouDepartment of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, 600 Yishan Road, Shanghai, 200233, China. zhoujian@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-1534-2279

Funding

China Youth Fund of National Natural Science Foundaion 61903071National Natural Science Foundation of China 61973067Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support 20161430
6 · The paper itself

Abstract

Continuous glucose monitoring (CGM) data analysis will provide a new perspective to analyze factors related to diabetic retinopathy (DR). However, the problem of visualizing CGM data and automatically predicting the incidence of DR from CGM is still controversial. Here, we explored the feasibility of using CGM profiles to predict DR in type 2 diabetes (T2D) by deep learning approach. This study fused deep learning with a regularized nomogram to construct a novel deep learning nomogram from CGM profiles to identify patients at high risk of DR. Specifically, a deep learning network was employed to mine the nonlinear relationship between CGM profiles and DR. Moreover, a novel nomogram combining CGM deep factors with basic information was established to score the patients' DR risk. This dataset consists of 788 patients belonging to two cohorts: 494 in the training cohort and 294 in the testing cohort. The area under the curve (AUC) values of our deep learning nomogram were 0.82 and 0.80 in the training cohort and testing cohort, respectively. By incorporating basic clinical factors, the deep learning nomogram achieved an AUC of 0.86 in the training cohort and 0.85 in the testing cohort. The calibration plot and decision curve showed that the deep learning nomogram had the potential for clinical application. This analysis method of CGM profiles can be extended to other diabetic complications by further investigation.

Indexed as

Deep LearningDiabetes Mellitus, Type 2Diabetic RetinopathyBlood GlucoseBlood Glucose Self-MonitoringHumansNomogramsBlood GlucoseContinuous glucose monitoringDeep learningDiabetic retinopathyType 2 diabetes

Identifiers

PMID37041318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.